Skip to main content

ADVERTISEMENT

Timothy D. Henry, MD

Clinical Editor's Corner
03/02/2021
How should we manage the ST-elevation myocardial infarction (STEMI) patient coming to the emergency department (ED) who appears to be so critically ill that further care would be futile?
How should we manage the ST-elevation myocardial infarction (STEMI) patient coming to the emergency department (ED) who appears to be so critically ill that further care would be futile?
How should we manage the...
03/02/2021
Cath Lab Digest
Feature
08/01/2008
Continued from previous page Overcoming heparin limitations in PCI with direct thrombin inhibitors Direct thrombin inhibitors, i.e., univalent agents such as argatroban, and bivalent agents such as lepirudin (Refludan®), desirudin (Revasc®)...
Continued from previous page Overcoming heparin limitations in PCI with direct thrombin inhibitors Direct thrombin inhibitors, i.e., univalent agents such as argatroban, and bivalent agents such as lepirudin (Refludan®), desirudin (Revasc®)...
Continued from previous...
08/01/2008
Journal of Invasive Cardiology
Clinical Editor's Corner
08/22/2023
Dr. Ajay Kirtane asks, “I know of a couple of other places who do [pre-cath] lipid testing, but I think it is by far the exception rather than the rule. What are your thoughts?”
Dr. Ajay Kirtane asks, “I know of a couple of other places who do [pre-cath] lipid testing, but I think it is by far the exception rather than the rule. What are your thoughts?”
Dr. Ajay Kirtane asks, “I know...
08/22/2023
Cath Lab Digest
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I...
08/01/2008
Journal of Invasive Cardiology
Original Research
04/14/2019
The burden and impact of sleep deprivation in cardiology has received limited study. We distributed a multidisciplinary, online survey on sleep health patterns and sleep deprivation involving 44 closed-ended questions to cardiovascular...
The burden and impact of sleep deprivation in cardiology has received limited study. We distributed a multidisciplinary, online survey on sleep health patterns and sleep deprivation involving 44 closed-ended questions to cardiovascular...
The burden and impact of sleep...
04/14/2019
Journal of Invasive Cardiology
Original Contribution
05/15/2015
Left main (LM) stenting is an accepted alternative to coronary artery bypass grafting. However, the LM bifurcation has great anatomic variability. The objective of this study was to quantify the LM bifurcation angles and their changes...
Left main (LM) stenting is an accepted alternative to coronary artery bypass grafting. However, the LM bifurcation has great anatomic variability. The objective of this study was to quantify the LM bifurcation angles and their changes...
Left main (LM) stenting is an...
05/15/2015
Journal of Invasive Cardiology
ST-Segment Elevation Myocardial Infarction and Out-of-Hospital Cardiac Arrest: Contemporary Management From the Multicenter START Registry
Original Contribution
01/13/2020
Abstract: Background. Recent studies suggest that primary percutaneous coronary intervention (PCI) and targeted temperature management (TTM) improve outcome in ST-segment elevation myocardial infarction (STEMI) complicated by out-of-hospital...
Abstract: Background. Recent studies suggest that primary percutaneous coronary intervention (PCI) and targeted temperature management (TTM) improve outcome in ST-segment elevation myocardial infarction (STEMI) complicated by out-of-hospital...
Abstract: Background. Recent...
01/13/2020
Journal of Invasive Cardiology